Response of low-grade oligodendroglial tumors to temozolomide

Journal of Neuro-Oncology

Volumn 70, Issue 3, 2004, Pages 279-280

  Byrne, Thomas N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ASTROCYTOMA; BONE MARROW SUPPRESSION; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIVITY; CHROMOSOME 1P; CHROMOSOME DELETION; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG TOLERABILITY; EDITORIAL; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; OLIGODENDROGLIOMA; SEIZURE; SIDE EFFECT;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CONTROLLED CLINICAL TRIALS; DACARBAZINE; HUMANS; LOSS OF HETEROZYGOSITY; OLIGODENDROGLIOMA; TREATMENT OUTCOME;

EID: 11244323398     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-5896-4     Document Type: Editorial

References (10)

1. G Cairncross D Macdonald D Ludwin et al. 1994 JCO 12 2013-2021
2. NA Paleologos DR Macdonald NA Vick JR Cairncross Neurology 53 1141 1999
3. Y Ino RA Betensky MC Zlatescu 2001 Clinical Ca Res 7 839-845
4. JG Cairncross K Ueki MC Zlatescu 1998 JNCI 90 1473-1479
5. MJ bent van den MJB Taphoorn AA Brandes 2003 JCO 21 2525-2528
6. O-L Chinot S Honore H Dufour 2001 JCO 19 2449-2455
7. JD Olson E Riedel LM DeAngelis 2000 Neurology 54 1442-1448
8. JC Buckner D Gesme JR O'Fallon 2003 JCO 21 251-255
9. K Hoang-Xuan L Capelle M Kujas 2004 JCO 22 3133-3138
10. JA Quinn DA Reardon AH Friedman 2003 JCO 21 646-651